Oncology/Hematology > > Other Cancers– News, functions, and commentary about cancer-related problems
by Charles Bankhead, Senior Editor, MedPage Today December 5, 2024
A breath test supported by expert system attained 94% precision for spotting 4 typical kinds of cancer, consisting of 95% precision for discovering early illness. (Scientific Reports
In a brand-new study, radiation oncologists blamed prior permission hold-ups for several damages to clients, consisting of hospitalizations, treatment desertion, and even deaths. (American Society for Radiation Oncology
Cancer treatment progressively consists of individualized treatments before surgical treatment, according to a report from the American College of Surgeons' National Cancer Database.
An online study of individuals with a history of cancer recommended that lots of clients would not trade faster access to brand-new cancer drugs for the unsure survival advantage connected with surrogate endpoints that are frequently utilized to support FDA sped up approval. (Lancet Oncology
Brian Druker, MD, whose discovery of imatinib (Gleevec) led the way for targeted cancer treatments, revealed his resignation as head of the Knight Cancer Institute in Portland, Oregon, asserting that management of Oregon Health & & Science University had actually “forgotten our objective.” (Willamette Week
Main outcomes of a stage III trial revealed that including tumor-treating fields (a type of low-level electrical present) to chemotherapy enhanced survival in pancreatic cancer versus chemotherapy alone, Novocure revealed.
Registration has actually started in a medical trial to examine a “pill-on-a-thread” gadget to screen for Barrett's esophagus, a precursor to esophageal cancer in numerous clients. (Medical Trials Arena
A previous scientist at Nemours Children's Health in Wilmington, Delaware, confessed to falsifying and improperly reporting information in 2 NIH-funded research studies. (Retraction Watch
More than 70% of a little group of clients with non-muscle intrusive bladder cancer in a stage II trial accomplished total reactions to an investigational cellular immunotherapy, consisting of all 4 clients with BCG-unresponsive illness, Protara Therapeutics revealed.
High-intensity focused ultrasound for freshly identified prostate cancer accomplished a rate of salvage therapy-free survival comparable to extreme prostatectomy, however with less negative impacts, a potential research study revealed. (European Urology
Cars and truck T-cell treatment boosted with interleukin-15 revealed initial activity versus glypican-3-expressing hepatocellular cancer in grownups and numerous strong growths in pediatric clients. (Baylor College of Medicine Nature
-
Charles Bankhead is senior editor for oncology and likewise covers urology, dermatology, and ophthalmology. He signed up with MedPage Today in 2007. Follow
